HOUSTON, TX — March 4, 2026 — Leads & Copy — Baylor Genetics will showcase its latest scientific studies and product innovations at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting, which will be held March 10-14 in Baltimore, MD.
The company will be at booth #1017 and will share a series of presentations and poster sessions throughout the meeting.
According to Christine Eng, MD, Chief Medical Officer and Chief Quality Officer at Baylor Genetics, the studies being shared at ACMG reinforce the power of genome sequencing in providing answers to complex genetic disorders, from rare pediatric diseases to patients receiving answers needed to support their care plans. She added that scientific advancements play a fundamental role in transforming the future of care, and the company is proud to highlight how its latest findings and product innovations are enabling clinical teams to deliver more timely answers and informed care plans for patients and their families.
A presentation titled “Putting Patients First: Innovative Multiomic and Multimodal Solutions for Rare Disease Diagnostics” will feature Christine Eng, MD and Chris Sands, Chief Growth Officer at Baylor Genetics. The session will take place in Exhibit Theater 2 on Friday, March 13 from 12:30-1:00 p.m. EST.
Lisa Salz, MS, CGC, Senior Medical Science Liaison at Baylor Genetics, will present a platform presentation titled “Diagnostic Yield of Rapid Genome Sequencing in Critically Ill Infants with Cardiac Indications,” on Friday, March 13 at 1:30 p.m. EST on Platform 8, Ballroom IV – Rapid WGS and Newborn Screening.
Poster presentations will also be given on Thursday, March 12 from 10:30 – 11:30 a.m. EST:
Poster #P177: Prevalence of Incidental Findings in Pharmacogenomic Panel Testing, presented by Lauren Marcath, PharmD
Poster #P501: Demographic and Geographic Considerations in Pediatric Genome Sequencing: A Diagnostic Laboratory Review, presented by Chad Moretz, ScD
Poster #P561: Expanding the Genotypic Spectrum for ReNU Syndrome: A Clinical Laboratory Experience, presented by Robert Rigobello, MS, CGC
Poster #P581: The Utility of Genome Sequencing as a Diagnostic Tool for Children with Ataxia, presented by Morgan Driver, PhD, MS, CGC
Poster #P661: Uniparental Disomy Detection in a Clinical Trio Genome Sequencing Cohort, presented by Bo Yuan, PhD
Poster presentations will also be given on Friday, March 13 from 10:30 – 11:30 a.m. EST:
Poster #P196: WDTC1 Haploinsufficiency is Associated with the Development of Neurodevelopmental Phenotypes and Seizures, presented by Elyssa Smith, BS
Poster #P564: Genome and Exome Sequencing Reanalysis: Improvement to Diagnostic Yield and Classification of Variants Over Time, presented by Morgan Driver, PhD, MS, CGC
Poster #P676: Sex Chromosome Abnormalities Are a Major CMA and Chromosome Diagnostic Finding for Ambiguous Genitalia, presented by Laleh Abbassi, PhD
Poster #P696: Genome Sequencing Diagnoses Atypical 7q11.23 Region Deletion in an Adult Patient, presented by Nichole Owen, PhD, FACMG
Poster #P710: Diagnostic Utility of Genome and Transcriptome Sequencing in Identifying PIGL Variants Associated with Atypical CHIME Syndrome, presented by Hongzheng Dai, PhD
Baylor Genetics is a diagnostic genomics partner offering genetic tests and diagnostic services, including Whole Genome Sequencing, Whole Exome Sequencing, and focused panels. Baylor Genetics combines precision diagnostics options with the support of genetic counselors to help clinicians avoid a diagnostic odyssey for their patients, guide medical management, and ensure no patient with a genetic disorder gets left behind. Baylor Genetics’ testing menu covers family planning, pregnancy, neonatal and pediatric testing, oncology, pharmacogenomics and specialized testing options. Located in Houston’s Texas Medical Center, Baylor Genetics serves clients in 50 states.
For more information about Baylor Genetics’ presence at ACMG, visit: https://www.baylorgenetics.com/conferences/acmg-2026/. Updates will also be shared on the company’s LinkedIn channel throughout the meeting.
Source: Baylor Genetics
